Irish medtech Orthoxel nailing a successful expansion in the USA

The global intramedullary nail market is valued at €2bn, with the tibia and femoral market segments worth €800m

OrthoXel, a medtech firm whose secondary bone healing system, Apex Tibial Nail, is the next evolution in fracture fixation.

Medical device company OrthoXel was founded to create innovative orthopaedic trauma instruments that are inspired by surgeons and focused on delivering superior patient outcomes. 

Company culture is guided by a philosophy of evidence-based design through a team drawn from large multinational medical device firms, regulatory agencies, academia and clinical research companies.